U.S. Renal Care en las noticias
Servicios de atención para enfermedades renales
Tamtam encontró 20 artículos recientes sobre U.S. Renal Care.
- U.S. Renal Care & Satellite Healthcare Honor 25 Nurses with National DAISY Award During Nephrology Nurses Week
- Waystar reports 80 percent time savings for US Renal Care in recoupment management
- PHTI report finds limited impact from virtual kidney care solutions, prompting industry pushback
- US Special Situations: US Renal Care looks to unwind asset strip move from 2023 LME in latest refi plan – Report
- US Renal Care Number of Employees 2026 | Employee Count & Headcount Data
- Kidney care provider expands access to new therapy
- US Special Situations: US Renal Care looks to unwind asset strip move from 2023 LME in latest refi plan – Report
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- Bain’s US Renal Care Seeks to Undo Asset Strip in Rare Debt Move
- U.S. Renal Care Premieres Short Film About One Runner's Race for Kidney Disease Awareness
- U.S. Renal Care and Akebia Therapeutics, Inc. Announce Interim Analysis of VOICE Trial Demonstrates Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo Versus ESA
- U.S. Renal Care and Akebia Announce Interim Analysis of
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
- Vafseo trial stops early after safety win in dialysis patients
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como U.S. Renal Care?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares